Role of Neuroprotective Agents in Neurodegenerative Disorders Neurodegenerative disorders are characterized by the progressive loss of neurons over time. Conditions such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease involve complex pathological processes that neuroprotective agents aim to slow. These disorders often involve protein misfolding, oxidative stress, inflammation, and impaired cellular clearance mechanisms. Neuroprotective agents may help reduce toxic protein accumulation or enhance neuronal resilience. Rather than reversing disease, neuroprotection focuses on preserving remaining neurons and delaying functional decline. Even modest slowing of neuronal loss can significantly affect quality of life. Reference - https://www.marketresearchfuture.com/reports/neuroprotective-agents-market-43126